Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study is a test of the safety and effectiveness of two drugs, one for diabetes and one
for hypertension, in keeping patients with high lab values of glucose from progressing to
frank diabetes and developing cardiovascular complications. People in this study cannot have
frank diabetes but are considered "borderline" based on blood tests. People in the study take
none, one or both of the drugs and do not know which one(s) they are taking.